385
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3

ORCID Icon, , &
Pages 306-315 | Received 03 Nov 2016, Accepted 15 Aug 2017, Published online: 05 Jan 2018

References

  • Siegel RL, Miller KD, and Jemal A: Cancer statistics, 2015. CA Cancer J Clin 65, 25–29, 2015.
  • Gennari A, Conte P, Rosso R, Orlandini C, and Bruzzi P: Survival of metastatic breast carcinoma patients over a 20‐year period. Cancer 104, 1742–1750, 2005. doi:10.1002/cncr.21359
  • Twelves C, Jove M, Gombos A, and Awada A: Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer. Crit Rev Oncol Hematol 100, 74–87, 2016. doi:10.1016/j.critrevonc.2016.01.021
  • Carrick S, Parker S, Thornton CE, Ghersi D, Simes J, et al.: Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Library Syst Rev 15, CD003372, 2009.
  • Baker J, Ajani J, Scotté F, Winther D, Martin M, et al.: Docetaxel-related side effects and their management. Eur J Oncol Nurs 13, 49–59, 2009. doi:10.1016/j.ejon.2008.10.003
  • O'Reilly EA, Gubbins L, Sharma S, Tully R, Guang MH, et al.: The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin 3, 257–275, 2015. doi:10.1016/j.bbacli.2015.03.003
  • Ribeiro JT, Macedo LT, Curigliano G, Fumagalli L, Locatelli M, et al.: Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future? Ann Oncol 23, 547–555, 2012. doi:10.1093/annonc/mdr382
  • Smith AR, and Andreansky S: Antitumor Immunity and Dietary Compounds. Med Sci 2, 1–22, 2013.
  • Buck K, Zaineddin AK, Vrieling A, Heinz J, Linseisen J, et al.: Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer. Br J Cancer 105, 1151–1157, 2011. doi:10.1038/bjc.2011.374
  • McCann SE, Thompson LU, Nie J, Dorn J, Trevisan M, et al.: Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat 122, 229–235, 2012. doi:10.1007/s10549-009-0681-x
  • Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, et al.: Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev 16, 2285–2292, 2007. doi:10.1158/1055-9965.EPI-07-0245
  • Zhang W, Wang X, Liu Y, Tian H, Flickinger B, et al.: Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 99, 1301–1309, 2008. doi:10.1017/S0007114507871649
  • Begum AN, Nicolle C, Mila I, Lapierre C, Nagano K, et al.: Dietary lignins are precursors of mammalian lignans in rats. J Nutr 134, 120–127, 2004.
  • Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, et al.: Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 17, 169–180, 2006. doi:10.1007/s10552-005-0342-2
  • Rowland I, Faughnan M, Hoey L, Wähälä K, Williamson G, et al.: Bioavailability of phyto-oestrogens. Br J Nutr 89, S45–S58, 2003.
  • Mukker JK, Michel D, Muir AD, Krol ES, and Alcorn J: Permeability and conjugative metabolism of flaxseed lignans by Caco-2 human intestinal cells. J Nat Prod 77, 29–34, 2014. doi:10.1021/np4004905
  • Van De Wetering K, Feddema W, Helms JB, Brouwers JF, and Borst P: Targeted metabolomics identifies glucuronides of dietary phytoestrogens as a major class of MRP3 substrates in vivo. Gastroenterology 137, 1725–1735, 2009. doi:10.1053/j.gastro.2009.06.052
  • Seibold P, Vrieling A, Johnson TS, Buck K, Behrens S, et al.: Enterolactone concentrations and prognosis after postmenopausal breast cancer: Assessment of effect modification and meta‐analysis. Int J Cancer 135, 923–933, 2014. doi:10.1002/ijc.28729
  • Guglielmini P, Rubagotti A, and Boccardo F: Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. Breast Cancer Res Treat 132, 661–668, 2012. doi:10.1007/s10549-011-1881-8
  • Buck K, Vrieling A, Zaineddin AK, Becker S, Husing A, et al.: Serum enterolactone and prognosis of postmenopausal breast cancer. J Clin Oncol 29, 3730–3738, 2011. doi:10.1200/JCO.2011.34.6478
  • Olsen A, Christensen J, Knudsen KEB, Johnsen NF, Overvad K, et al.: Prediagnostic plasma enterolactone levels and mortality among women with breast cancer. Breast Cancer Res Treat 128, 883–889, 2011. doi:10.1007/s10549-011-1397-2
  • Setchell KD, Brown NM, Zimmer-Nechemias L, Wolfe B, Jha P, et al.: Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food Funct 5, 491–501, 2014. doi:10.1039/C3FO60402K
  • Sugahara T, Yamauchi S, Nishimoto S, Kondo A, Ohno F, et al.: The structure-activity relationships of flaxseed lignan, secoisolariciresinol. Interdisciplinary Stud Environ Chem—Biol Responses Chem Pollutants 1, 263–268, 2008.
  • Liang C, Li H, Zhou H, Zhang S, Liu Z, et al.: Recombinant Lz-8 from Ganoderma lucidum induces endoplasmic reticulum stress-mediated autophagic cell death in SGC-7901 human gastric cancer cells. Oncol Rep 27, 1079–1089, 2012. doi:10.3892/or.2011.1593
  • Xiao J, Wang Y, Peng J, Guo L, Hu J, et al.: A synthetic compound, 1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one (B63), induces apoptosis and activates endoplasmic reticulum stress in non-small cell lung cancer cells. Int J Cancer 131, 1455–1465, 2012. doi:10.1002/ijc.27406
  • Saggar JK, Chen J, Corey P, and Thompson LU: Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF‐7 tumor growth through estrogen receptor‐and growth factor‐signaling pathways. Mol Nutr Food Res 54, 415–425, 2015. doi:10.1002/mnfr.200900068
  • Chen J, Power KA, Mann J, Cheng A, and Thompson LU: Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways. Nutr Cancer 58, 162–170, 2007. doi:10.1080/01635580701328271.
  • Billinsky J, Glew RA, Cornish SM, Whiting SJ, Thorpe LU, et al.: No evidence of hypoglycemia or hypotension in older adults during 6 months of flax lignan supplementation in a randomized controlled trial: a safety evaluation. Pharm Biol 51, 778–782, 2013. doi:10.3109/13880209.2013.766220
  • Peuhu E, Rivero-Muller A, Stykki H, Torvaldson E, Holmbom T, et al.: Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis. Oncogene 29, 898–908, 2010. doi:10.1038/onc.2009.386
  • Patterson S: Metformin may have broad utility in cancer. [https://www.mdanderson.org/publications/oncolog/november-december-2014/beyond-diabetes-metformin-may-have-broad-utility-in-cancer.html] MD Anderson Cancer Center 2014 [cited 2016 July].
  • Bodmer M, Meier C, Krähenbühl S, Jick SS, and Meier CR: Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33, 1304–1308, 2010. doi:10.2337/dc09-1791
  • Col NF, Ochs L, Springmann V, Aragaki AK, and Chlebowski RT: Metformin and breast cancer risk: a meta-analysis and critical literature review. Breast Cancer Res Treat 135, 639–646, 2012. doi:10.1007/s10549-012-2170-x
  • Lin C, Krol S, and Alcorn J: The comparison of rat and human intestinal and hepatic glucuronidation of enterolactone derived from flaxseed lignans. Nat Prod J 3, 159–171, 2013.
  • Kotlyarova V: Pharmacokinetics of Flaxseed Lignans in the Rat (Thesis). 2011.
  • Szerémy P, Pál Á, Méhn D, Tóth B, Fülöp F, et al.: Comparison of 3 assay systems using a common probe substrate, calcein AM, for studying P-gp using a selected set of compounds. J Biomol Screen 16, 112–119, 2011. doi:10.1177/1087057110385230
  • Chou T-C: Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70, 440–446, 2010. doi:10.1158/0008-5472.CAN-09-1947
  • Mueller H, Kassack MU, and Wiese M: Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines. J Biomol Screen 9, 506–515, 2004. doi:10.1177/1087057104265386
  • Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, et al.: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707–712, 1989. doi:10.1126/science.2470152
  • Foulkes WD, Smith IE, and Reis-Filho JS: Triple-negative breast cancer. N Engl J Med 363, 1938–1948, 2010. doi:10.1056/NEJMra1001389
  • Hicks DG, and Kulkarni S: HER2+ breast cancer review of biologic relevance and optimal use of diagnostic tools. Am J Clin Pathol 129, 263–273, 2008. doi:10.1309/99AE032R9FM8WND1
  • Chen J, Hui E, Ip T, and Thompson LU: Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin Cancer Res 10, 7703–7711, 2004. doi:10.1158/1078-0432.CCR-04-1130
  • Chen J, Power KA, Mann J, Cheng A, and Thompson LU: Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp Biol Med 232, 1071–1080, 2007.
  • Obermeyer W, Musser S, Betz J, Casey R, Pohland A, and Page S, editors: Chemical studies of phytoestrogens and related compounds in dietary supplements: flax and chaparral. Proc Soc Exp Biol Med 208, 6–12, 1995.
  • Eeckhaut E, Struijs K, Possemiers S, Vincken J-P, Keukeleire DD, et al.: Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem. J Agric Food Chem 56, 4806–4812, 2008. doi:10.1021/jf800101s
  • Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, et al.: Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58, 47–52, 2001. doi:10.1016/S0090-4295(01)01014-7
  • Corazzari M, Gagliardi M, Fimia GM, and Piacentini M: Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front Oncol 7, 78, 2017. doi:10.3389/fonc.2017.00078
  • Mukker JK, Singh RSP, Muir AD, Krol ES, and Alcorn J: Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats. Br J Nutr 113, 749–757, 2015. doi:10.1017/S0007114514004371
  • Kajbaf F, De Broe ME, and Lalau J-D: Therapeutic concentrations of metformin: a systematic review. Clin Pharmacokinet 55, 439–459, 2016. doi:10.1007/s40262-015-0323-x
  • Wahdan-Alaswad RS, Cochrane DR, Spoelstra NS, Howe EN, Edgerton SM, et al.: Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Horm Cancer 5, 374–389, 2014. doi:10.1007/s12672-014-0188-8
  • Zhuang Y, Chan DK, Haugrud AB, and Miskimins WK: Mechanisms by which low glucose enhances the cytotoxicity of metformin to cancer cells both in vitro and in vivo. PLoS One 9, e108444, 2014. doi:10.1371/journal.pone.0108444
  • Ide T, Ashakumary L, Takahashi Y, Kushiro M, Fukuda N, et al.: Sesamin, a sesame lignan, decreases fatty acid synthesis in rat liver accompanying the down-regulation of sterol regulatory element binding protein-1. Biochim Biophys Acta 1534, 1–13, 2001. doi:10.1016/S1388-1981(01)00167-6.
  • Ward WE, Chen J, and Thompson LU: Exposure to flaxseed or its purified lignan during suckling only or continuously does not alter reproductive indices in male and female offspring. J Toxicol Environ Health A 7, 567–577, 2001. doi:10.1080/15287390152627246
  • Pelicano H, Zhang W, Liu J, Hammoudi N, Dai J, et al.: Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential. Breast Cancer Res 16, 434, 2014. doi:10.1186/s13058-014-0434-6
  • Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, et al.: Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol 1, 778–784, 2015. doi:10.1001/jamaoncol.2015.2378
  • Banerjee A, Ahmed H, Yang P, Czinn SJ, and Blanchard TG: Endoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatment. Oncotarget 7, 41432–41444, 2016. doi:10.18632/oncotarget.9180

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.